Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 4, 2011, Pages 731-738

  Matsuda, Masanori ^a   Asakawa, Masami ^a   Amemiya, Hidetake ^a   Fujii, Hideki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Clinical treatment; Hepatocellular carcinoma; Lens culinaris agglutinin reactive fraction; Multicentric occurrence; Repeat hepatic resection; fetoprotein

Indexed keywords

AGGLUTININ; ALPHA FETOPROTEIN; INTERFERON;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LENTIL; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL;

EID: 79952834170     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06532.x     Document Type: Article

References (26)

1. Nagasue N, Kohno H, Hayashi T etal. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br. J. Surg. 1996; 83: 127-31.
2. Hu RH, Lee PH, Yu SC etal. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996; 120: 23-9.
3. Shimada M, Takenaka K, Taguchi K etal. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann. Surg. 1998; 227: 80-5.
4. Poon RT, Fan ST, Lo CM etal. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann. Surg. 1999; 229: 216-22.
5. Matsuda M, Fujii H, Kono H etal. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J. Hepatobiliary Pancreat. Surg. 2001; 8: 353-9.
6. Sugimachi K, Maehara S, Tanaka S etal. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg. 2001; 8: 410-6.
7. Lu MD, Yin XY, Xie XY etal. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br. J. Surg. 2005; 92: 1393-8.
8. Itamoto T, Nakahara H, Amano H etal. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 2007; 141: 589-97.
9. Minagawa M, Makuuchi M, Takayama T etal. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann. Surg. 2003; 238: 703-10.
10. Nagano Y, Shimada H, Ueda M etal. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas. ANZ J. Surg. 2009; 79: 729-33.
11. Aoyagi Y, Isemura M, Suzuki Y etal. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells. Lancet 1986; 1: 210.
12. Sato Y, Nakata K, Kato Y etal. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N. Engl. J. Med. 1993; 328: 1802-6.
13. Taketa K, Endo Y, Sekiya C etal. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993; 53: 5419-23.
14. Kuromatsu R, Tanaka M, Tanikawa K. Serum alpha-fetoprotein and Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Liver 1993; 13: 177-82.
15. Yamashita F, Tanaka M, Satomura S etal. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 1996; 111: 996-1001.
16. Aoyagi Y, Isokawa O, Suda T etal. The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 1998; 83: 2076-82.
17. Hayashi K, Kumada T, Nakano S etal. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am. J. Gastroenterol. 1999; 94: 3028-33.
18. Pugh RNH, Murray-Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-69.
19. Couinaud C. Le Foie Etudes Anatomiques Et Chirurgicales. Paris: Masson, 1957.
20. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002.
21. Matsumoto Y, Fujii H, Matsuda M etal. Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance. J. Hepatobiliary Pancreat. Surg. 2001; 8: 435-40.
22. Utsunomiya T, Okamoto M, Kameyama T etal. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J. Gastroenterol. 2008; 14: 1553-8.
23. Okuda K, Tanaka M, Kanazawa N etal. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by Lens culinaris agglutinin-reactive alpha-fetoprotein. Int. J. Oncol. 1999; 14: 265-71.
24. Tateishi R, Shiina S, Yoshida H etal. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006; 44: 1518-27.
25. Miyaaki H, Nakashima O, Kurogi M etal. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J. Gastroenterol. 2007; 42: 962-8.
26. Toyoda H, Kumada T, Kaneoka Y etal. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. J. Hepatol. 2008; 49: 223-32.